|
⚲
|
| Keyboard |
| Karoly Nikolich | |
|---|---|
| Firm | |
| Address | 501 Massachusetts Avenue Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Lucy Therapeutics Inc | 021-428117 | Director | 15.0 M of 20.0 M |
||
| Chase Therapeutics Corp | 021-320230 | Director | 4.0 M of 4.0 M |
||
| Chase Pharmaceuticals Corp | 021-260084 | Director | 12.0 M of 12.0 M |
||
| Chase Pharmaceuticals Corp | 021-257591 | Director | of 0.1 M |
||
| Chase Pharmaceuticals Corp | 021-257589 | Director | of 0.6 M |
||
| Biommune Technologies Inc | 021-252110 | Director | 0.6 M of 0.6 M |
||
| Chromaderm Inc | 021-249179 | Director | 3.6 M of 5.1 M |
||
| Chase Pharmaceuticals Corp | 021-246193 | Director | 3.5 M of 3.5 M |
||
| Alkahest Inc | 021-222149 | Executive Officer | 3.5 M of 3.5 M |
||
| Chase Pharmaceuticals Corp | 021-218283 | Director | 6.1 M of 8.6 M |
||
| Excelimmune Inc | 021-171053 | Director | 6.0 M of 12.0 M |
||
| Chase Pharmaceuticals Corp | 021-153008 | Director | 1.2 M of 1.2 M |
||
| Excelimmune Inc | 021-144413 | Director | 4.5 M of 9.0 M |
||